Hypomyelinating Leukodystrophy 3 C1850053
A genetic condition affecting the brain's white matter, leading to impaired myelin formation. It causes progressive motor and cognitive difficulties, usually beginning in early childhood. Treatment is supportive and involves multiple specialists.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Motor developmental delay
(neurologic)Spasticity
(neurologic)Optic atrophy
(neurologic)Sensorineural hearing loss
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Regular neurological monitoring
Periodic neurological examinations and imaging to track disease progression and evaluate treatment response. MRI imaging helps assess white matter changes over time.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Motor function maintenance therapy
Specialized physical therapy program focusing on maintaining muscle strength, balance, and mobility. Includes stretching, strengthening exercises, and gait training.
Additional treatment options
Seizure management
Anticonvulsant medications prescribed if seizures develop as part of disease progression. Selection based on seizure type and patient tolerability.
medicationNeuroimaging follow-up
Regular MRI scans to monitor white matter changes, brain atrophy, and treatment effectiveness. Used to guide clinical decisions.
procedureSupportive care and assistive devices
Provision of mobility aids such as walkers, wheelchairs, and adaptive equipment to maintain independence and quality of life.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Hypomyelinating Leukodystrophy 3 C1850053?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Hypomyelinating Leukodystrophy 3 C1850053. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy